
A growing controversy among people challenges the prevailing belief about the sequencing of SS31 and Mots C for optimal health benefits. New insights from forums show mixed reactions, with many pushing back against established recommendations.
Fresh discussions indicate that individuals are questioning the need to take SS31 before Mots C. One commenter stated, "You donβt need to do SS31 before Mots. There's really no clinical data at all to support that." This reflects a growing skepticism regarding current protocols centered on mitochondrial health.
Several contributors are trying different approaches. One user shared their rotation plan: "I keep them on a rotation: 2 vials of Mots C, then 1 vial of SS31." This shift toward personalized protocols suggests that people are finding success through various methods, emphasizing the need for tailored supplementation.
Despite the lack of clinical evidence to support many claims, people continue to share their experiences with these supplements. One commenter cautioned, saying, "Whatβs good for you could kill me." They encouraged others to learn from personal trials and adjust their intake based on individual responses.
Interestingly, another participant running SS31 reported fatigue but viewed it positively, noting, "Apparently, that means my body is doing the mitochondrial repair work."
The conversations reveal a split in sentiment:
Skeptical voices: Some participants discredit the current protocols, calling them theoretical rather than backed by data.
Support for mixed strategies: Others advocate for taking both supplements together or apart, experiencing varied benefits.
β οΈ Increasing skepticism about the need for strict sequencing of SS31 and Mots C.
βοΈ Users are experimenting with different protocols, including simultaneous intake and rotation methods.
π Emphasis on individualized experiences and adjustment based on personal health conditions remains strong.
As discussions unfold, it's clear that the understanding of these supplements is evolving, with many people looking for what truly works for them.